Management committed to a massive spending ramp right at the bottom of the cycle.
Thesis: This is a classic cyclical bottom with a structural kicker. The market is fixated on the Q4 16% gross margin trough, missing the operating leverage inherent in the recovery. Management's decision to hike CapEx by 50% amidst a downturn is the ultimate insider buy signal—they see the order book. The $250M AI packaging revenue is small now, but it validates the technology roadmap. You buy the operating leverage turn, not the current print.
Verdict: LONG — Conviction: HIGH
Catalyst: Q2 earnings report showing the pivot to growth and the first improved margin print, confirming the H2 trajectory.
Key Risk: Yield issues on advanced packaging or a delayed inventory correction pushing the recovery into 2025, leaving them with high fixed costs from new CapEx.
The Tell: When pressed on advanced packaging margins, the CEO joked, 'I think that you just forced us to say that' before admitting it was 'not dilutive.' This confirms they don't have pricing power on the high-end stuff yet—it's a volume play, not a margin play.
Friction Level: MODERATE_FRICTION — Margin trajectory. The Street sees 16% trough margins; management is guiding a structural return to 25-30% in H2, creating a massive valuation disconnect if executed.
Report not found
The report data is no longer available. Please return to the archive.